×

Active Pharmaceutical Ingredients (API) Global Market - Forecast to 2020

Dublin, Nov. 28, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/hdwzd4/active) has announced the addition of the "Active Pharmaceutical Ingredients (API) Global Market - Forecast to 2020" report to their offering.

Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on diagnosis, prevention or treatment of disease in human and other animals. API's are manufactured by chemical synthesis, fermentation, biotechnological methods or recovered from natural source.

Active pharmaceutical ingredient is the important component of every formulated product of pharmaceutical industry and has enormous therapeutic application in the field of cancer, multiple myeloma, respiratory disorders and hormonal imbalance. These ingredients are used in cardiovascular and hematopoietic system, genito-urinary system and as anti-infectives

Overall API market is expected to growth at a CAGR of more than 8.0% from 2014 to 2019. The factors such as expiry of patented drugs and shift towards the use of low cost API drugs due to economic recession are driving the growth of active pharmaceutical ingredients market. In addition, the rising adoption of high potent active pharmaceutical ingredients effective in targeted therapy is boosting the global API market growth. While the challenges faced by the market include transparency and increased market fragmentation.

Globally North America accounts the largest share in the API market. Asia-Pacific is second largest followed by Europe. Asia is growing at a highest CAGR compared to North America followed by Europe. The key players of Active Pharmaceutical Ingredient market are Sandoz-Lek-Biochemie (Switzerland), GlaxoSmithKline Pharmaceuticals Limited (India), AstraZeneca plc (U.K.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.) and F. Hoffmann-La Roche Ltd. (Switzerland).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis

4 Global Api Market Overview

5 Global Api Market, By Therapeutic Application

6 Regional Market Analysis

7 Company Developments

8 Major Player Profiles


Companies Mentioned:

  • Albemarle Corporation
  • Aurobindo Pharma Limited
  • Boehringer Ingelheim Gmbh
  • Dr. Reddy'S Laboratories Limited
  • Fresenius Kabi
  • Lonza Group Ltd
  • Lupin Limited
  • Novartis International Ag
  • Ranbaxy Laboratories Limited
  • Sun Pharmaceuticals Industries Ltd
  • Teva Active Pharmaceutical Ingredients




For more information visit http://www.researchandmarkets.com/research/hdwzd4/active

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Pharmaceuticals

Source:Research and Markets